Kidney Cancer Drugs Market Insights, Forecast to 2026

1. Report Title: Global and United States Kidney Cancer Drugs Market Insights, Forecast to 2026 Published On: October 2020 Category: Life Sciences Pages: 177 Report Overview: Kidney Cancer Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Kidney Cancer Drugs market is segmented into Angiogenesis Inhibitors mTOR Inhibitors Monoclonal Antibodies Cytokine Immunotherapy (IL-2) Segment by Application, the Kidney Cancer Drugs market is segmented into Renal cell carcinoma (RCC) Transitional cell carcinoma (TCC) Regional and Country-level Analysis The Kidney Cancer Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Kidney Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. 24marketreports | International +1 646 781 7170 | www.24marketreports.com

2. Competitive Landscape and Kidney Cancer Drugs Market Share Analysis Kidney Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Kidney Cancer Drugs business, the date to enter into the Kidney Cancer Drugs market, Kidney Cancer Drugs product introduction, recent developments, etc. The major vendors covered: Bayer Roche GlaxoSmithKline Novartis Pfizer Abbott Laboratories Active Biotech Amgen Argos Therapeutics ArQule AVEO Pharmaceuticals Bionomics Bristol-Myers Squibb Cerulean Pharma Exelixis Genentech immatics biotechnologies Immunicum Ono Pharmaceutical Onyx Therapeutics Oxford BioMedica Prometheus Laboratories Seattle Genetics Taiwan Liposome Tracon Pharmaceuticals Wilex Table of Contents: 1 Study Coverage 1.1 Kidney Cancer Drugs Product Introduction 1.2 Market Segments 1.3 Key Kidney Cancer Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Kidney Cancer Drugs Market Size Growth Rate by Type 1.4.2 Angiogenesis Inhibitors 24marketreports | International +1 646 781 7170 | www.24marketreports.com

3. 1.4.3 mTOR Inhibitors 1.4.4 Monoclonal Antibodies 1.4.5 Cytokine Immunotherapy (IL-2) 1.5 Market by Application 1.5.1 Global Kidney Cancer Drugs Market Size Growth Rate by Application 1.5.2 Renal cell carcinoma (RCC) 1.5.3 Transitional cell carcinoma (TCC) 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Kidney Cancer Drugs Market Size, Estimates and Forecasts 2.1.1 Global Kidney Cancer Drugs Revenue 2015-2026 2.1.2 Global Kidney Cancer Drugs Sales 2015-2026 2.2 Global Kidney Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Kidney Cancer Drugs Historical Market Size by Region (2015-2020) 2.3.1 Global Kidney Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Kidney Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Kidney Cancer Drugs Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Kidney Cancer Drugs Sales Forecast by Region (2021-2026) 2.4.2 Global Kidney Cancer Drugs Revenue Forecast by Region (2021-2026) 3 Global Kidney Cancer Drugs Competitor Landscape by Players 3.1 Global Top Kidney Cancer Drugs Sales by Manufacturers 3.1.1 Global Kidney Cancer Drugs Sales by Manufacturers (2015-2020) 3.1.2 Global Kidney Cancer Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Global Kidney Cancer Drugs Manufacturers by Revenue 3.2.1 Global Kidney Cancer Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Global Kidney Cancer Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Kidney Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Kidney Cancer Drugs Revenue in 2019 3.2.5 Global Kidney Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Kidney Cancer Drugs Price by Manufacturers 3.4 Global Kidney Cancer Drugs Manufacturing Base Distribution, Product Types 3.4.1 Kidney Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Kidney Cancer Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Kidney Cancer Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Kidney Cancer Drugs Market Size by Type (2015-2020) 4.1.1 Global Kidney Cancer Drugs Sales by Type (2015-2020) 4.1.2 Global Kidney Cancer Drugs Revenue by Type (2015-2020) 4.1.3 Kidney Cancer Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Kidney Cancer Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Kidney Cancer Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Kidney Cancer Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Kidney Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 24marketreports | International +1 646 781 7170 | www.24marketreports.com

4. 4.3 Global Kidney Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High- End 5 Market Size by Application (2015-2026) 5.1 Global Kidney Cancer Drugs Market Size by Application (2015-2020) 5.1.1 Global Kidney Cancer Drugs Sales by Application (2015-2020) 5.1.2 Global Kidney Cancer Drugs Revenue by Application (2015-2020) 5.1.3 Kidney Cancer Drugs Price by Application (2015-2020) 5.2 Kidney Cancer Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Kidney Cancer Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Kidney Cancer Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Kidney Cancer Drugs Price Forecast by Application (2021-2026) 6 United States by Players, Type and Application 6.1 United States Kidney Cancer Drugs Market Size YoY Growth 2015-2026 6.1.1 United States Kidney Cancer Drugs Sales YoY Growth 2015-2026 6.1.2 United States Kidney Cancer Drugs Revenue YoY Growth 2015-2026 6.1.3 United States Kidney Cancer Drugs Market Share in Global Market 2015-2026 6.2 United States Kidney Cancer Drugs Market Size by Players (International and Local Players) 6.2.1 United States Top Kidney Cancer Drugs Players by Sales (2015-2020) 6.2.2 United States Top Kidney Cancer Drugs Players by Revenue (2015-2020) 6.3 United States Kidney Cancer Drugs Historic Market Review by Type (2015-2020) 6.3.1 United States Kidney Cancer Drugs Sales Market Share by Type (2015-2020) 6.3.2 United States Kidney Cancer Drugs Revenue Market Share by Type (2015-2020) 6.3.3 United States Kidney Cancer Drugs Price by Type (2015-2020) 6.4 United States Kidney Cancer Drugs Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States Kidney Cancer Drugs Sales Forecast by Type (2021-2026) 6.4.2 United States Kidney Cancer Drugs Revenue Forecast by Type (2021-2026) 6.4.3 United States Kidney Cancer Drugs Price Forecast by Type (2021-2026) 6.5 United States Kidney Cancer Drugs Historic Market Review by Application (2015-2020) 6.5.1 United States Kidney Cancer Drugs Sales Market Share by Application (2015-2020) 6.5.2 United States Kidney Cancer Drugs Revenue Market Share by Application (2015-2020) 6.5.3 United States Kidney Cancer Drugs Price by Application (2015-2020) 6.6 United States Kidney Cancer Drugs Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States Kidney Cancer Drugs Sales Forecast by Application (2021-2026) 6.6.2 United States Kidney Cancer Drugs Revenue Forecast by Application (2021-2026) 6.6.3 United States Kidney Cancer Drugs Price Forecast by Application (2021-2026) 7 North America 7.1 North America Kidney Cancer Drugs Market Size YoY Growth 2015-2026 7.2 North America Kidney Cancer Drugs Market Facts & Figures by Country 7.2.1 North America Kidney Cancer Drugs Sales by Country (2015-2020) 7.2.2 North America Kidney Cancer Drugs Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Kidney Cancer Drugs Market Size YoY Growth 2015-2026 24marketreports | International +1 646 781 7170 | www.24marketreports.com

5. 8.2 Europe Kidney Cancer Drugs Market Facts & Figures by Country 8.2.1 Europe Kidney Cancer Drugs Sales by Country 8.2.2 Europe Kidney Cancer Drugs Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Kidney Cancer Drugs Market Size YoY Growth 2015-2026 9.2 Asia Pacific Kidney Cancer Drugs Market Facts & Figures by Country 9.2.1 Asia Pacific Kidney Cancer Drugs Sales by Region (2015-2020) 9.2.2 Asia Pacific Kidney Cancer Drugs Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Kidney Cancer Drugs Market Size YoY Growth 2015-2026 10.2 Latin America Kidney Cancer Drugs Market Facts & Figures by Country 10.2.1 Latin America Kidney Cancer Drugs Sales by Country 10.2.2 Latin America Kidney Cancer Drugs Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Kidney Cancer Drugs Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Kidney Cancer Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Kidney Cancer Drugs Sales by Country 11.2.2 Middle East and Africa Kidney Cancer Drugs Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Bayer 12.1.1 Bayer Corporation Information 12.1.2 Bayer Description and Business Overview 24marketreports | International +1 646 781 7170 | www.24marketreports.com

6. 12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Bayer Kidney Cancer Drugs Products Offered 12.1.5 Bayer Recent Development 12.2 Roche 12.2.1 Roche Corporation Information 12.2.2 Roche Description and Business Overview 12.2.3 Roche Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Roche Kidney Cancer Drugs Products Offered 12.2.5 Roche Recent Development 12.3 GlaxoSmithKline 12.3.1 GlaxoSmithKline Corporation Information 12.3.2 GlaxoSmithKline Description and Business Overview 12.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 12.3.4 GlaxoSmithKline Kidney Cancer Drugs Products Offered 12.3.5 GlaxoSmithKline Recent Development 12.4 Novartis 12.4.1 Novartis Corporation Information 12.4.2 Novartis Description and Business Overview 12.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Novartis Kidney Cancer Drugs Products Offered 12.4.5 Novartis Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Description and Business Overview 12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Pfizer Kidney Cancer Drugs Products Offered 12.5.5 Pfizer Recent Development 12.6 Abbott Laboratories 12.6.1 Abbott Laboratories Corporation Information 12.6.2 Abbott Laboratories Description and Business Overview 12.6.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Abbott Laboratories Kidney Cancer Drugs Products Offered 12.6.5 Abbott Laboratories Recent Development 12.7 Active Biotech 12.7.1 Active Biotech Corporation Information 12.7.2 Active Biotech Description and Business Overview 12.7.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Active Biotech Kidney Cancer Drugs Products Offered 12.7.5 Active Biotech Recent Development 12.8 Amgen 12.8.1 Amgen Corporation Information 12.8.2 Amgen Description and Business Overview 12.8.3 Amgen Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Amgen Kidney Cancer Drugs Products Offered 12.8.5 Amgen Recent Development 12.9 Argos Therapeutics 12.9.1 Argos Therapeutics Corporation Information 12.9.2 Argos Therapeutics Description and Business Overview 24marketreports | International +1 646 781 7170 | www.24marketreports.com

7. 12.9.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Argos Therapeutics Kidney Cancer Drugs Products Offered 12.9.5 Argos Therapeutics Recent Development 12.10 ArQule 12.10.1 ArQule Corporation Information 12.10.2 ArQule Description and Business Overview 12.10.3 ArQule Sales, Revenue and Gross Margin (2015-2020) 12.10.4 ArQule Kidney Cancer Drugs Products Offered 12.10.5 ArQule Recent Development 12.11 Bayer 12.11.1 Bayer Corporation Information 12.11.2 Bayer Description and Business Overview 12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Bayer Kidney Cancer Drugs Products Offered 12.11.5 Bayer Recent Development 12.12 Bionomics 12.12.1 Bionomics Corporation Information 12.12.2 Bionomics Description and Business Overview 12.12.3 Bionomics Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Bionomics Products Offered 12.12.5 Bionomics Recent Development 12.13 Bristol-Myers Squibb 12.13.1 Bristol-Myers Squibb Corporation Information 12.13.2 Bristol-Myers Squibb Description and Business Overview 12.13.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Bristol-Myers Squibb Products Offered 12.13.5 Bristol-Myers Squibb Recent Development 12.14 Cerulean Pharma 12.14.1 Cerulean Pharma Corporation Information 12.14.2 Cerulean Pharma Description and Business Overview 12.14.3 Cerulean Pharma Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Cerulean Pharma Products Offered 12.14.5 Cerulean Pharma Recent Development 12.15 Exelixis 12.15.1 Exelixis Corporation Information 12.15.2 Exelixis Description and Business Overview 12.15.3 Exelixis Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Exelixis Products Offered 12.15.5 Exelixis Recent Development 12.16 Genentech 12.16.1 Genentech Corporation Information 12.16.2 Genentech Description and Business Overview 12.16.3 Genentech Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Genentech Products Offered 12.16.5 Genentech Recent Development 12.17 immatics biotechnologies 12.17.1 immatics biotechnologies Corporation Information 12.17.2 immatics biotechnologies Description and Business Overview 24marketreports | International +1 646 781 7170 | www.24marketreports.com

8. 12.17.3 immatics biotechnologies Sales, Revenue and Gross Margin (2015-2020) 12.17.4 immatics biotechnologies Products Offered 12.17.5 immatics biotechnologies Recent Development 12.18 Immunicum 12.18.1 Immunicum Corporation Information 12.18.2 Immunicum Description and Business Overview 12.18.3 Immunicum Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Immunicum Products Offered 12.18.5 Immunicum Recent Development 12.19 Ono Pharmaceutical 12.19.1 Ono Pharmaceutical Corporation Information 12.19.2 Ono Pharmaceutical Description and Business Overview 12.19.3 Ono Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.19.4 Ono Pharmaceutical Products Offered 12.19.5 Ono Pharmaceutical Recent Development 12.20 Onyx Therapeutics 12.20.1 Onyx Therapeutics Corporation Information 12.20.2 Onyx Therapeutics Description and Business Overview 12.20.3 Onyx Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.20.4 Onyx Therapeutics Products Offered 12.20.5 Onyx Therapeutics Recent Development 12.21 Oxford BioMedica 12.21.1 Oxford BioMedica Corporation Information 12.21.2 Oxford BioMedica Description and Business Overview 12.21.3 Oxford BioMedica Sales, Revenue and Gross Margin (2015-2020) 12.21.4 Oxford BioMedica Products Offered 12.21.5 Oxford BioMedica Recent Development 12.22 Prometheus Laboratories 12.22.1 Prometheus Laboratories Corporation Information 12.22.2 Prometheus Laboratories Description and Business Overview 12.22.3 Prometheus Laboratories Sales, Revenue and Gross Margin (2015-2020) 12.22.4 Prometheus Laboratories Products Offered 12.22.5 Prometheus Laboratories Recent Development 12.23 Seattle Genetics 12.23.1 Seattle Genetics Corporation Information 12.23.2 Seattle Genetics Description and Business Overview 12.23.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020) 12.23.4 Seattle Genetics Products Offered 12.23.5 Seattle Genetics Recent Development 12.24 Taiwan Liposome 12.24.1 Taiwan Liposome Corporation Information 12.24.2 Taiwan Liposome Description and Business Overview 12.24.3 Taiwan Liposome Sales, Revenue and Gross Margin (2015-2020) 12.24.4 Taiwan Liposome Products Offered 12.24.5 Taiwan Liposome Recent Development 12.25 Tracon Pharmaceuticals 12.25.1 Tracon Pharmaceuticals Corporation Information 12.25.2 Tracon Pharmaceuticals Description and Business Overview 24marketreports | International +1 646 781 7170 | www.24marketreports.com

9. 12.25.3 Tracon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.25.4 Tracon Pharmaceuticals Products Offered 12.25.5 Tracon Pharmaceuticals Recent Development 12.26 Wilex 12.26.1 Wilex Corporation Information 12.26.2 Wilex Description and Business Overview 12.26.3 Wilex Sales, Revenue and Gross Margin (2015-2020) 12.26.4 Wilex Products Offered 12.26.5 Wilex Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter?s Five Forces Analysis 13.5 Primary Interviews with Key Kidney Cancer Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Kidney Cancer Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer Get More Information about the Report: Report URL: https://www.24marketreports.com/life-sciences/global-united-states-kidney-cancer-drugs-2026-517 To get Report Sample: https://www.24marketreports.com/request-sample/global-united-states-kidney-cancer-drugs-2026-517 24marketreports | International +1 646 781 7170 | www.24marketreports.com